Publications by authors named "Masuo Akahane"

Claim this Profile
K
KTO-7924, a Beta3-adrenergic receptor agonist, reduces hyperglycemia, and protects beta-cells in the islets of langerhans of db/db mice.
Fumiki Oana, Hiroo Takeda, Akane Matsuzawa, Satoshi Akahane, Morimichi Hayashi, Masuo Akahane

Endocr Res· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA microarray analysis of white adipose tissue from obese (fa/fa) Zucker rats treated with a beta3-adrenoceptor agonist, KTO-7924.
Fumiki Oana, Toshiki Homma, Hiroo Takeda, Akane Matsuzawa, Satoshi Akahane, Masuo Akahane

Pharmacol Res· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physiological difference between obese (fa/fa) Zucker rats and lean Zucker rats concerning adiponectin.
Fumiki Oana, Hiroo Takeda, Kohichi Hayakawa, Akane Matsuzawa, Satoshi Akahane, Masuo Akahane

Metabolism· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adiponectin receptor 2 expression in liver and insulin resistance in db/db mice given a beta3-adrenoceptor agonist.
Fumiki Oana, Hiroo Takeda, Akane Matsuzawa, Satoshi Akahane, Masayuki Isaji, Masuo Akahane

Eur J Pharmacol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different inhibitory effects in the early and late phase of treatment with KAT-681, a liver-selective thyromimetic, on rat hepatocarcinogenesis induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation.
Morimichi Hayashi, Toru Tamura, Junji Kuroda, Hideki Ohnota, Nobuo Shibata, Masuo Akahane

Toxicol Sci· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitory effects of KAT-681, a liver-selective thyromimetic, on development of hepatocellular proliferative lesions in rats induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation.
Morimichi Hayashi, Hideki Ohnota, Toru Tamura, Junji Kuroda, Nobuo Shibata, Masuo Akahane

Arch Toxicol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional characterization of beta-adrenoceptor subtypes in the canine and rat lower urinary tract.
Hiroo Takeda, Akane Matsuzawa, Yasuhiko Igawa, Yoshinobu Yamazaki, Kouich Kaidoh, Satoshi Akahane, Masuo Akahane

J Urol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological profile of KUL-7211, a selective beta-adrenoceptor agonist, in isolated ureteral smooth muscle.
Yoshitaka Tomiyama, Makoto Murakami, Kohichi Hayakawa, Katsuyoshi Akiyama, Yoshinobu Yamazaki, Masuo Akahane

J Pharmacol Sci· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison between CL-316243- and CGP-12177A-induced relaxations in isolated canine ureter.
Yoshitaka Tomiyama, Makoto Murakami, Yoshinobu Yamazaki, Masami Kojima, Masuo Akahane

Pharmacology· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of beta(3)-adrenoceptor stimulation on prostaglandin E(2)-induced bladder hyperactivity and on the cardiovascular system in conscious rats.
Hiroo Takeda, Yoshinobu Yamazaki, Yasuhiko Igawa, Kouichi Kaidoh, Satoshi Akahane, Masuo Akahane

Neurourol Urodyn· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between stereochemistry and the beta3-adrenoceptor agonistic activity of 4'-hydroxynorephedrine derivative as an agent for treatment of frequent urination and urinary incontinence.
Nobuyuki Tanaka, Tetsuro Tamai, Harunobu Mukaiyama, Akihito Hirabayashi, Hideyuki Muranaka, Satoshi Akahane, Masuo Akahane

J Med Chem· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KUR-1246, a novel beta(2)-adrenoceptor agonist, as a tocolytic agent.
Sumiyoshi Kiguchi, Tadashi Matsuda, Kazutoshi Cho, Kazuhiko Okuyama, Masuo Akahane

Obstet Gynecol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modification of ureteral motility and promotion of urine flow around an intraureteral obstruction by CL-316243, phenylephrine, and furosemide in dogs.
Yoshitaka Tomiyama, Makoto Murakami, Katsuyoshi Akiyama, Masami Kojima, Masuo Akahane

Neurourol Urodyn· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diversity of inhibitory responses to beta2-stimulants shown by term-pregnant human myometria in vitro is partly due to differences in receptor density.
Tomoko Sakakibara, Yoshihito Inoue, Satoshi Uzue, Takuji Tsukamoto, Mamoru Kobayashi, Masuo Akahane

Am J Obstet Gynecol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrate and statin synergistically increase the transcriptional activities of PPARalpha/RXRalpha and decrease the transactivation of NFkappaB.
Ikuo Inoue, Fumiaki Itoh, Shigemi Aoyagi, Shigeki Tazawa, Hiroshi Kusama, Masuo Akahane

Biochem Biophys Res Commun· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of beta-adrenoceptor subtype in bladder smooth muscle in cynomolgus monkey.
Hiroo Takeda, Yoshinobu Yamazaki, Masuo Akahane, Satoshi Akahane, Hiroshi Miyata

Jpn J Pharmacol· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis